vs

Side-by-side financial comparison of D-Wave Quantum Inc. (QBTS) and TScan Therapeutics, Inc. (TCRX). Click either name above to swap in a different company.

D-Wave Quantum Inc. is the larger business by last-quarter revenue ($2.8M vs $2.6M, roughly 1.1× TScan Therapeutics, Inc.). TScan Therapeutics, Inc. runs the higher net margin — -895.1% vs -1538.0%, a 642.9% gap on every dollar of revenue. On growth, TScan Therapeutics, Inc. posted the faster year-over-year revenue change (286.0% vs 19.2%). D-Wave Quantum Inc. produced more free cash flow last quarter ($-20.0M vs $-32.2M). Over the past eight quarters, D-Wave Quantum Inc.'s revenue compounded faster (-2.7% CAGR vs -9.7%).

D-Wave Quantum Inc. is a quantum computing company with locations in Palo Alto, California and Burnaby, British Columbia. D-Wave claims to be the world's first company to sell computers that exploit quantum effects in their operation. D-Wave's early customers include Lockheed Martin, the University of Southern California, Google/NASA, and Los Alamos National Laboratory.

TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel T cell receptor (TCR) immunotherapies for hard-to-treat cancers. Its proprietary platform identifies high-affinity naturally occurring TCRs targeting tumor antigens, with pipeline candidates spanning hematological malignancies and solid tumors, operating in the global oncology therapeutics market.

QBTS vs TCRX — Head-to-Head

Bigger by revenue
QBTS
QBTS
1.1× larger
QBTS
$2.8M
$2.6M
TCRX
Growing faster (revenue YoY)
TCRX
TCRX
+266.8% gap
TCRX
286.0%
19.2%
QBTS
Higher net margin
TCRX
TCRX
642.9% more per $
TCRX
-895.1%
-1538.0%
QBTS
More free cash flow
QBTS
QBTS
$12.1M more FCF
QBTS
$-20.0M
$-32.2M
TCRX
Faster 2-yr revenue CAGR
QBTS
QBTS
Annualised
QBTS
-2.7%
-9.7%
TCRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
QBTS
QBTS
TCRX
TCRX
Revenue
$2.8M
$2.6M
Net Profit
$-42.3M
$-23.0M
Gross Margin
64.8%
Operating Margin
-1266.0%
-929.4%
Net Margin
-1538.0%
-895.1%
Revenue YoY
19.2%
286.0%
Net Profit YoY
50.8%
35.8%
EPS (diluted)
$-0.13
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
QBTS
QBTS
TCRX
TCRX
Q4 25
$2.8M
$2.6M
Q3 25
$3.7M
$2.5M
Q2 25
$3.1M
$3.1M
Q1 25
$15.0M
$2.2M
Q4 24
$2.3M
Q3 24
$1.0M
Q2 24
$2.2M
Q1 24
$2.5M
Net Profit
QBTS
QBTS
TCRX
TCRX
Q4 25
$-42.3M
$-23.0M
Q3 25
$-140.0M
$-35.7M
Q2 25
$-167.3M
$-37.0M
Q1 25
$-5.4M
$-34.1M
Q4 24
$-86.1M
Q3 24
$-29.9M
Q2 24
$-17.8M
Q1 24
$-17.3M
Gross Margin
QBTS
QBTS
TCRX
TCRX
Q4 25
64.8%
Q3 25
71.4%
Q2 25
63.8%
Q1 25
92.5%
Q4 24
63.8%
Q3 24
Q2 24
63.6%
Q1 24
67.3%
Operating Margin
QBTS
QBTS
TCRX
TCRX
Q4 25
-1266.0%
-929.4%
Q3 25
-741.8%
-1475.6%
Q2 25
-856.3%
-1256.6%
Q1 25
-75.3%
-1669.7%
Q4 24
-876.2%
Q3 24
-3109.8%
Q2 24
-863.0%
Q1 24
-710.6%
Net Margin
QBTS
QBTS
TCRX
TCRX
Q4 25
-1538.0%
-895.1%
Q3 25
-3743.9%
-1422.1%
Q2 25
-5406.4%
-1201.3%
Q1 25
-36.1%
-1571.9%
Q4 24
-3727.9%
Q3 24
-2849.1%
Q2 24
-814.4%
Q1 24
-702.3%
EPS (diluted)
QBTS
QBTS
TCRX
TCRX
Q4 25
$-0.13
$-0.18
Q3 25
$-0.41
$-0.28
Q2 25
$-0.55
$-0.28
Q1 25
$-0.02
$-0.26
Q4 24
$-0.43
Q3 24
$-0.25
Q2 24
$-0.10
Q1 24
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
QBTS
QBTS
TCRX
TCRX
Cash + ST InvestmentsLiquidity on hand
$884.5M
$152.4M
Total DebtLower is stronger
$32.5M
Stockholders' EquityBook value
$852.2M
$123.1M
Total Assets
$915.8M
$228.8M
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
QBTS
QBTS
TCRX
TCRX
Q4 25
$884.5M
$152.4M
Q3 25
$836.2M
$184.5M
Q2 25
$819.3M
$218.0M
Q1 25
$304.3M
$251.7M
Q4 24
$178.0M
Q3 24
$271.1M
Q2 24
Q1 24
Total Debt
QBTS
QBTS
TCRX
TCRX
Q4 25
$32.5M
Q3 25
$32.4M
Q2 25
$32.3M
Q1 25
$32.2M
Q4 24
Q3 24
$30.6M
Q2 24
Q1 24
Stockholders' Equity
QBTS
QBTS
TCRX
TCRX
Q4 25
$852.2M
$123.1M
Q3 25
$670.6M
$144.0M
Q2 25
$694.3M
$176.7M
Q1 25
$207.4M
$210.2M
Q4 24
$62.6M
Q3 24
$229.1M
Q2 24
$-21.5M
Q1 24
$-37.0M
Total Assets
QBTS
QBTS
TCRX
TCRX
Q4 25
$915.8M
$228.8M
Q3 25
$865.8M
$262.2M
Q2 25
$843.6M
$298.6M
Q1 25
$325.6M
$332.7M
Q4 24
$199.9M
Q3 24
$348.0M
Q2 24
$61.8M
Q1 24
$48.6M
Debt / Equity
QBTS
QBTS
TCRX
TCRX
Q4 25
0.26×
Q3 25
0.23×
Q2 25
0.18×
Q1 25
0.15×
Q4 24
Q3 24
0.13×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
QBTS
QBTS
TCRX
TCRX
Operating Cash FlowLast quarter
$-18.4M
$-32.0M
Free Cash FlowOCF − Capex
$-20.0M
$-32.2M
FCF MarginFCF / Revenue
-727.9%
-1253.3%
Capex IntensityCapex / Revenue
60.3%
6.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-75.8M
$-139.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
QBTS
QBTS
TCRX
TCRX
Q4 25
$-18.4M
$-32.0M
Q3 25
$-19.0M
$-32.5M
Q2 25
$-15.3M
$-33.3M
Q1 25
$-19.3M
$-37.6M
Q4 24
$2.0M
Q3 24
$-27.9M
Q2 24
$-14.5M
Q1 24
$-12.1M
Free Cash Flow
QBTS
QBTS
TCRX
TCRX
Q4 25
$-20.0M
$-32.2M
Q3 25
$-20.1M
$-33.9M
Q2 25
$-16.0M
$-34.5M
Q1 25
$-19.7M
$-39.1M
Q4 24
$1.1M
Q3 24
$-29.3M
Q2 24
$-15.0M
Q1 24
$-12.4M
FCF Margin
QBTS
QBTS
TCRX
TCRX
Q4 25
-727.9%
-1253.3%
Q3 25
-536.5%
-1349.6%
Q2 25
-518.1%
-1123.1%
Q1 25
-131.4%
-1801.8%
Q4 24
46.2%
Q3 24
-2792.0%
Q2 24
-687.7%
Q1 24
-504.0%
Capex Intensity
QBTS
QBTS
TCRX
TCRX
Q4 25
60.3%
6.7%
Q3 25
27.2%
56.8%
Q2 25
24.2%
41.6%
Q1 25
2.9%
70.6%
Q4 24
41.1%
Q3 24
130.6%
Q2 24
25.0%
Q1 24
12.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

QBTS
QBTS

Transferred Over Time$2.4M89%
Other$306.0K11%

TCRX
TCRX

Segment breakdown not available.

Related Comparisons